Dublin, April 10, 2019 (GLOBE NEWSWIRE) -- The "Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global live cell encapsulation market is expected to reach USD 302.8 million by 2024 from USD 250.2 million in 2018, at a CAGR of 3.2%.
Cell encapsulation technology helps to minimize the requirement for the long-term use of immunosuppressive drugs after an organ transplant in order to control side effects. Various key application areas in cell encapsulation field include drug delivery, regenerative medicine, cell transplantation, and probiotics.
The growth of this market is majorly driven by the increasing incidence of target diseases, rising adoption of novel drug delivery systems for disease treatment, technology advancements, increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management.
However, high manufacturing costs, the limited availability of high-quality raw materials, and the significant adoption of alternative therapies are expected to restrain market growth during the forecast period.
In 2017, BioTime, Inc. (US), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (US), Neurotech Pharmaceuticals, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top five players in the global live cell encapsulation market.
Other prominent players operating in this market are Merck KGAA (Germany), Sigilon Therapeutics, Inc. (US), Encapsys, LLC (US), Evonik Industries (Germany), Lycored (Israel), MiKroCaps (Slovenia), BCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), Sernova Corporation (Canada), and Balchem Corporation (US), among others.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Live Cell Encapsulation Market Overview
4.2 Europe: Live Cell Encapsulation Market, By Polymer Type
4.3 Global Live Cell Encapsulation Market, By Technique
4.4 Live Cell Encapsulation Market, By Application
4.5 Live Cell Encapsulation Market, By Country
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Target Diseases
5.2.1.2 Focus on Novel Drug Delivery Systems for Disease Treatment
5.2.1.3 Technology Advancements
5.2.1.4 Increasing Public-Private Investments to Support Novel Product Development
5.2.1.5 Rising Public Awareness Related to the Clinical Role of Encapsulated Cells in Disease Management
5.2.2 Restraints
5.2.2.1 High Product Manufacturing Costs
5.2.2.2 Limited Market Availability of High-Quality Raw Materials
5.2.3 Opportunities
5.2.3.1 Rising Research Activity
5.2.4 Challenges
5.2.4.1 Adoption of Alternative Therapies
6 Live Cell Encapsulation Market, By Manufacturing Techniques
6.1 Introduction
6.2 Simple Dripping
6.2.1 Global Live Cell Encapsulation: Market Split for Simple Dripping Technique, By Application
6.3 Electrostatic Dripping
6.3.1 Global Live Cell Encapsulation: Market Split for Electrostatic Dripping Technique, By Application
6.4 Coaxial Airflow
6.4.1 Global Live Cell Encapsulation: Market Split for Coaxial Airflow Technique, By Application
6.5 Liquid-Jet Break-Up
6.5.1 Global Live Cell Encapsulation: Market Split for Liquid Jet Break Up Technique, By Application
6.6 Vibrating-Jet Technique
6.6.1 Global Live Cell Encapsulation: Market Split for Vibrating Jet Technique, By Application
6.7 Jet Cutting
6.7.1 Global Live Cell Encapsulation: Market Split for Jet Cutting Technique, By Application
6.8 Rotating Disk Atomization
6.8.1 Global Live Cell Encapsulation: Market Split for Rotating Disk Atomization Technique, By Application
7 Live Cell Encapsulation Market, By Polymer Type
7.1 Introduction
7.2 Alginate
7.2.1 Alginate is the Most Widely Adopted Material for the Encapsulation of Living Cells
7.3 Hema-Mma
7.3.1 Hema-Mma-Based Products are Used Mainly for Liver Transplantation Procedures and Diabetes Management
7.4 Chitosan
7.4.1 Inadequate Availability of Natural Chitosan Sources is Expected to Hamper Market Growth
7.5 Siliceous Encapsulates
7.5.1 Procedural Benefits Offered By Siliceous Encapsulates Such as Effective Process Control & High Process Adjustability to Drive Market Growth
7.6 Cellulose Sulfate
7.6.1 Techno-Commercial Benefits Such as High Mechanical Stability & Adjustability to Drive Market Growth
7.7 PAN-PVC
7.7.1 PAN-PVC Polymers Have Mechanical Stability, Permeability, and High Biocompatibility
7.8 Other Polymers
8 Live Cell Encapsulation Market, By Application
8.1 Introduction
8.2 Drug Delivery
8.2.1 Drug Delivery Forms the Largest Application Segment of the Live Cell Encapsulation Market
8.3 Regenerative Medicine
8.3.1 Clinical Risk of Clogging in the Hepatic Vascular System is Expected to Hamper the Adoption of Cell Encapsulation for Regenerative Medicine
8.4 Cell Transplantation
8.4.1 Increasing Incidence of Target Diseases & Technological Advancements in the Field of Cell Transplantation to Support Market Growth
8.5 Probiotics
8.5.1 Probiotics Applications to Register the Highest Growth During the Forecast Period
8.6 Research
8.6.1 Growing Awareness About the Research Applications of Cell Encapsulation Techniques and the Increasing Availability of Public-Private Funding, Investments, & Grants to Drive Market Growth
9 Live Cell Encapsulation Market, By Region
10 Competitive Landscape
10.1 Overview
10.2 Global Market Share Analysis (2017)
10.3 Competitive Scenario (2015 to 2019)
10.4 Competitive Leadership Mapping
10.4.1 Vendor Inclusion Criteria
10.4.1.1 Visionary Leaders
10.4.1.2 Innovators
10.4.1.3 Dynamic Differentiators
10.4.1.4 Emerging Companies
11 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/57ox9k
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomaterials